Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAd63 RH5 and MVA RH5 malaria vaccines in healthy volunteers
NCT02181088Phase 1Completed
- Sponsor
- University of Oxford
- Start
- Aug 2014
- Primary completion
- Oct 2015
- Modality
- Prophylactic Vaccines, Viral Vectors, DNA Vaccines
- Countries
- 1
01
Overview
Phase 1, open-label trial of ChAd63 RH5 and MVA RH5 in malaria, sponsored by University of Oxford. Started Aug 2014; status: completed.
02
Drugs
ChAd63 RH5MVA RH5
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02181088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02181088.